Resources Library
CEO Paul Bishop and President Lyle Camblos on "Are There Too Many CROs?"
Each quarter, ARG CEO Paul Bishop and President Lyle Camblos will share their thoughts and responses concerning relevant company and […]
May 22, 2018
ARG Presence at Alliance For Regenerative Medicine Annual Dinner & Legislative Fly-In
Jeff Cazeault, Head of Business Development at ARG, is in Washington, DC to attend the Alliance for Regenerative Medicine Annual […]
May 22, 2018
Project Manager Katherine Pryor Test Drives Kanban
Earlier this year we introduced ARG’s use of Kanban as an organizational model–and tool, as many team members employed a […]
May 15, 2018
Does Your CRO Innovate To Keep Trials On Track?
ARG knows from experience that the willingness to be flexible has fueled our success in rare disease clinical trials, resulting in approvals with over $3B in sales.
May 9, 2018
ARG successfully starts up a Phase II trial within 6 weeks
Challenge: In an economic downturn, small biotech companies often depend on clinical milestones in order to maximize shareholder value and […]
May 1, 2018
Shay Brill: Judge for Clinical Researcher of the Year Competition
Shay Brill, ARG Vice President of Corporate Development, recently had the privilege and distinction of serving as a judge in […]
April 30, 2018